Inhibition of N-glycosylation induces tyrosine sulphation of hybridoma immunoglobulin G.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMC 557672)

Published in EMBO J on October 01, 1984

Authors

P A Baeuerle, W B Huttner

Articles citing this

A single N-linked oligosaccharide at either of the two normal sites is sufficient for transport of vesicular stomatitis virus G protein to the cell surface. Mol Cell Biol (1985) 2.78

(Glu62, Ala30, Tyr8)n serves as high-affinity substrate for tyrosylprotein sulfotransferase: a Golgi enzyme. Proc Natl Acad Sci U S A (1985) 1.39

The major tyrosine-sulfated protein of the bovine anterior pituitary is a secretory protein present in gonadotrophs, thyrotrophs, mammotrophs, and corticotrophs. J Cell Biol (1985) 1.32

Nature of sulphated macromolecules in mouse Reichert's membrane. Evidence for tyrosine O-sulphate in basement-membrane proteins. Biochem J (1985) 1.11

Analysis of sequence requirements for protein tyrosine sulfation. Protein Sci (1993) 0.92

Role of N-linked glycans in antigenicity, processing, and cell surface expression of bovine herpesvirus 1 glycoprotein gIV. J Virol (1993) 0.89

Tyrosine sulfation of proteins from the human hepatoma cell line HepG2. Proc Natl Acad Sci U S A (1985) 0.88

Rapid catabolism of tyrosine-O-sulphated proteins and the formation of free tyrosine O-sulphate as an end product in rat embryo fibroblasts. Biochem J (1987) 0.83

Polarized secretion of tyrosine-sulphated proteins and free tyrosine O-sulphate by filter-grown Madin-Darby canine kidney (MDCK) cells. Biochem J (1991) 0.83

Cholecystokinin-associated COOH-terminal peptides are fully sulfated in pig brain. Proc Natl Acad Sci U S A (1986) 0.79

Identification and characterization of tyrosylprotein sulfotransferase from human saliva. Int J Biol Sci (2005) 0.79

Tyrosine sulfation of statherin. Int J Biol Sci (2007) 0.79

Studies of the decrease of tyrosine-O-sulphated proteins in Rous sarcoma-virus-transformed rat embryo fibroblasts, line 3Y1. Examination of the sulphate activation and tyrosyl-protein sulphotransferase systems. Biochem J (1987) 0.75

Articles by these authors

Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J (1991) 11.86

The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product. Cell (1990) 9.37

Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J Cell Biol (1983) 7.55

Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature (1993) 6.75

The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J (1991) 6.08

Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B. Science (1991) 5.52

Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med (1992) 5.32

Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J (1995) 5.24

Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun (1992) 4.45

Purified human I kappa B can rapidly dissociate the complex of the NF-kappa B transcription factor with its cognate DNA. Cell (1990) 4.37

Endophilin I mediates synaptic vesicle formation by transfer of arachidonate to lysophosphatidic acid. Nature (1999) 4.15

Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci U S A (1997) 4.04

A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J (1994) 4.04

H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J (1993) 3.94

Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology (1998) 3.82

Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-kappa B subunit. Cell (1992) 3.73

Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature (1995) 3.59

Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat Cell Biol (2000) 3.55

The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation. Genes Dev (1991) 3.52

Synapsin I (Protein I), a nerve terminal-specific phosphoprotein. II. Its specific association with synaptic vesicles demonstrated by immunocytochemistry in agarose-embedded synaptosomes. J Cell Biol (1983) 3.49

The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem (2000) 3.33

Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus. EMBO J (1993) 3.30

NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO J (1991) 3.28

IKAP is a scaffold protein of the IkappaB kinase complex. Nature (1998) 3.28

Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat Cell Biol (2000) 3.27

Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell (1996) 3.00

The 65-kD subunit of NF-kappa B is a receptor for I kappa B and a modulator of DNA-binding specificity. Genes Dev (1990) 2.98

Multiple phosphorylation sites in protein I and their differential regulation by cyclic AMP and calcium. Proc Natl Acad Sci U S A (1979) 2.96

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest (1996) 2.96

Nuclear import-export: in search of signals and mechanisms. Cell (1991) 2.82

DNA binding of purified transcription factor NF-kappa B. Affinity, specificity, Zn2+ dependence, and differential half-site recognition. J Biol Chem (1991) 2.80

A role for oxygen radicals as second messengers. Trends Cell Biol (1991) 2.72

Chlorate--a potent inhibitor of protein sulfation in intact cells. Biochem Biophys Res Commun (1986) 2.57

Secretogranins I and II: two tyrosine-sulfated secretory proteins common to a variety of cells secreting peptides by the regulated pathway. J Cell Biol (1985) 2.53

The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits. Biochem J (1993) 2.49

Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br J Cancer (2006) 2.45

Sulphation of tyrosine residues-a widespread modification of proteins. Nature (1982) 2.39

The primary structure of human secretogranin I (chromogranin B): comparison with chromogranin A reveals homologous terminal domains and a large intervening variable region. EMBO J (1987) 2.33

A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-kappa B. EMBO J (1995) 2.31

Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology (1993) 2.28

Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. Free Radic Biol Med (2000) 2.28

Differential phosphorylation of multiple sites in purified protein I by cyclic AMP-dependent and calcium-dependent protein kinases. J Biol Chem (1981) 2.26

Tyrosine-O-sulfated proteins of PC12 pheochromocytoma cells and their sulfation by a tyrosylprotein sulfotransferase. J Biol Chem (1983) 2.26

Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science (1996) 2.15

Cell-free protein sorting to the regulated and constitutive secretory pathways. Cell (1990) 2.12

Tyrosine sulfation is a trans-Golgi-specific protein modification. J Cell Biol (1987) 2.10

Milieu-induced, selective aggregation of regulated secretory proteins in the trans-Golgi network. J Cell Biol (1991) 2.07

Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum (1996) 2.07

The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B. Chem Biol (1995) 2.05

Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic (2001) 2.03

The ER-overload response: activation of NF-kappa B. Trends Biochem Sci (1997) 2.03

Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-kappa B. TNF alpha is not needed for induction of a biological effect via TNF receptors. J Biol Chem (1990) 1.99

Constitutive NF-kappa B activity in neurons. Mol Cell Biol (1994) 1.96

A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration. Hum Mol Genet (2000) 1.87

The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB. J Exp Med (1996) 1.87

Characterization of the immature secretory granule, an intermediate in granule biogenesis. J Cell Biol (1991) 1.87

Activate NF-kappa B or die? Curr Biol (1997) 1.85

Molecular mechanisms in down-regulation of tumor necrosis factor expression. Proc Natl Acad Sci U S A (1990) 1.83

XL alpha s is a new type of G protein. Nature (1995) 1.82

A novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene. EMBO J (1992) 1.81

Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.77

Sex reversal by loss of the C-terminal transactivation domain of human SOX9. Nat Genet (1996) 1.76

Secretory granule biogenesis: rafting to the SNARE. Trends Cell Biol (2001) 1.73

Synaptophysin and chromogranins/secretogranins--widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis. Virchows Arch B Cell Pathol Incl Mol Pathol (1989) 1.73

Expression of the antiproliferative gene TIS21 at the onset of neurogenesis identifies single neuroepithelial cells that switch from proliferative to neuron-generating division. Proc Natl Acad Sci U S A (1999) 1.73

Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis. J Cell Biol (1996) 1.71

Protein secretion: puzzling receptors. Curr Biol (1997) 1.71

Loss of occludin and functional tight junctions, but not ZO-1, during neural tube closure--remodeling of the neuroepithelium prior to neurogenesis. Dev Biol (1996) 1.69

NF-kappa B as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene. Mol Cell Biol (1990) 1.69

The NF-kappa B transcription factor induces DNA bending which is modulated by its 65-kD subunit. Nucleic Acids Res (1990) 1.69

Determination and occurrence of tyrosine O-sulfate in proteins. Methods Enzymol (1984) 1.68

Proteins controlling the nuclear uptake of NF-kappa B, Rel and dorsal. Trends Cell Biol (1991) 1.68

Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B. J Virol (1995) 1.63

Newly synthesized synaptophysin is transported to synaptic-like microvesicles via constitutive secretory vesicles and the plasma membrane. EMBO J (1991) 1.63

Activation of transcription factor NF-kappaB by the adenovirus E3/19K protein requires its ER retention. J Cell Biol (1996) 1.62

Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: Detection of FK506-binding protein 12 upregulation. Circulation (2001) 1.61

The primary structure of human secretogranin II, a widespread tyrosine-sulfated secretory granule protein that exhibits low pH- and calcium-induced aggregation. J Biol Chem (1989) 1.60

Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation. Proc Natl Acad Sci U S A (1999) 1.58

Interaction of the COOH-terminal transactivation domain of p65 NF-kappa B with TATA-binding protein, transcription factor IIB, and coactivators. J Biol Chem (1995) 1.53

The primary structure of bovine chromogranin A: a representative of a class of acidic secretory proteins common to a variety of peptidergic cells. EMBO J (1986) 1.52

Existence of distinct tyrosylprotein sulfotransferase genes: molecular characterization of tyrosylprotein sulfotransferase-2. Proc Natl Acad Sci U S A (1998) 1.51

Structural and functional analysis of the NF-kappa B p65 C terminus. An acidic and modular transactivation domain with the potential to adopt an alpha-helical conformation. J Biol Chem (1994) 1.50

Purified I kappa B-beta is inactivated upon dephosphorylation. J Biol Chem (1992) 1.50

A role for phosphatidylinositol transfer protein in secretory vesicle formation. Nature (1995) 1.50

The I kappa B kinase (IKK) complex is tripartite and contains IKK gamma but not IKAP as a regular component. J Biol Chem (2000) 1.49

Selective recognition of the activated form of transcription factor NF-kappa B by a monoclonal antibody. Biol Chem Hoppe Seyler (1995) 1.48

Two overlapping reading frames in a single exon encode interacting proteins--a novel way of gene usage. EMBO J (2001) 1.48

Requirement for GTP hydrolysis in the formation of secretory vesicles. Nature (1990) 1.47

Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings. Eur J Immunol (1996) 1.47

IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J (1995) 1.47

Multiple trimeric G-proteins on the trans-Golgi network exert stimulatory and inhibitory effects on secretory vesicle formation. EMBO J (1992) 1.46

Synaptic vesicle biogenesis. Annu Rev Cell Dev Biol (1999) 1.46

Free cytoplasmic Ca2+ and neurotransmitter release: studies on PC12 cells and synaptosomes exposed to alpha-latrotoxin. Proc Natl Acad Sci U S A (1984) 1.46

Synaptic-like microvesicles of neuroendocrine cells originate from a novel compartment that is continuous with the plasma membrane and devoid of transferrin receptor. J Cell Biol (1997) 1.44

T cell leukemia-associated human Notch/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cells. J Exp Med (1996) 1.44

The role of the p50 and p65 subunits of NF-kappa B in the recognition of cognate sequences. New Biol (1991) 1.43